Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes

1 de agosto de 2026 actualizado por: Seda Yıldız, Halic University

Investigation Of Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes: A Cross-Sectional Study

Paralympic athletes actively participate in many sports despite their physical limitations and continue to develop both individually and athletically. Assessing the physical and functional capacities of these athletes is important in terms of performance and health. This study aimed to examine the relationships between respiratory function, respiratory muscle strength, lung age, balance, and quality of life in Paralympic athletes. Additionally, it was evaluated whether there were significant differences in these parameters according to disability type and gender.

The study included 24 Paralympic athletes from the disciplines of athletics, swimming, archery, and wheelchair basketball. Participants had various orthopeadic and neurological disability types, including cerebral palsy, lower extremity amputation, spinal cord injuries (C5-T6 and T7 and below), hypotonia, poliomyelitis, spina bifida, brachial plexus injury, and short stature. Respiratory function was assessed using forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), FEV₁/FVC ratio, peak expiratory flow (PEF), and forced expiratory flow (FEF25-75%); respiratory muscle strength was assessed using maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP). Lung age was calculated based on FEV₁ values, balance was measured using the Modified Functional Reach Test, and quality of life was determined using the Short Form (SF-36) questionnaire. Significant correlations were found between parameters. Based on the study results, supporting respiratory muscle strength in Paralympic athletes may be an important goal in rehabilitation and training programs to support respiratory function, lung age, and quality of life parameters.

Descripción general del estudio

Estado

Terminado

Tipo de estudio

De observación

Inscripción (Actual)

24

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra de probabilidad

Población de estudio

Paralympic athletes who has been playing their sports minimum 1 year participated in the study.

Descripción

Inclusion Criteria:

  • Being between 18-50 years of age
  • Being registered with any of the sports federations in Turkey and being a licensed paralympic athlete for at least 1 year (
  • Having a lower extremity or upper extremity amputation or having permanent injuries as determined by the International Paralympic Committee

Exclusion Criteria:

  • Lack of consent to participate in the study.
  • Having undergone surgery within the last 6 months.
  • Having had a respiratory tract infection within the three weeks prior to the evaluations
  • FEV1/FVC < 0.7

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Forced expiratory volume in the first second (FEV1) (L)
Periodo de tiempo: 4 months

Pulmonary function (Forced expiratory volume in the first second FEV1)) was evaluated with a portable spirometer, COSMED Pony FX® (COSMED S.r.l., Italy) and measurements were performed according to European Respiratory Society standards.

Considering that dizziness may occur during forced expiration, measurements were made while individuals were in a sitting position. While participants were sitting in a comfortable position in a chair with a backrest, nose clip was attached and they were asked to bite the mouth teeth and close their lips in a way that did not allow air to escape. The tests were performed at least 3 times by the participants and care was taken to ensure that the expiration time was at least 6 seconds and the plateau time was 1 second. Due to the device software that records all three data, it saved the average of the two best data and processed it as a value.

4 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Forced vital capacity (FVC) (L)
Periodo de tiempo: 4 months
Pulmonary function ((Forced vital capacity (FVC )) was evaluated with a portable spirometer.
4 months
FEV1 / FVC (%)
Periodo de tiempo: 4 months
Pulmonary function (FEV1 / FVC) was evaluated with a spirometer.
4 months
Peak flow rate (PEF) (L/s)
Periodo de tiempo: 4 months
Pulmonary function (Peak flow rate (PEF)) was evaluated with a spirometer.
4 months
Flow rate 25-75% of forced expiratory volume (FEF 25-75%) (L/s)
Periodo de tiempo: 4 months
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) was evaluated with a spirometer.
4 months
Maximal expiratory pressure (MEP) (L)
Periodo de tiempo: 4 months
The MEP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
4 months
Maximal inspiratory pressure (MIP) (L)
Periodo de tiempo: 4 months
The MIP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
4 months
Balance
Periodo de tiempo: 4 months
Balance was measured using the Modified Functional Reach Test
4 months
Quality of Life
Periodo de tiempo: 4 months
Quality of life was determined using the Short Form-36 (SF-36) Health Survey that contains 36 questions and produces scores for eight health related quality of life domains. Each domain is transformed to a 0-100 scale. Higher scores represents better health status while lower stores represents poor health status.
4 months
Lung Age
Periodo de tiempo: 4 months
Lung age was calculated based on FEV₁ values. For male: Lung age (years)=(2.87×height in cm×0.394)-(31.25×FEV1 in L)-39.375 For females: Lung age (years)=(3.56×height in cm×0.394)-(40×FEV1 in L)-77.280
4 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de diciembre de 2024

Finalización primaria (Actual)

31 de mayo de 2025

Finalización del estudio (Actual)

30 de junio de 2025

Fechas de registro del estudio

Enviado por primera vez

26 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

1 de agosto de 2026

Publicado por primera vez (Actual)

6 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

1 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • Paralympic_Athlete

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Quality of life and balance results can be shared.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir